What's driving your type 2 diabetes risk, and what to do about it

A routine blood test comes back with your blood sugar flagged as "slightly high." Or a parent gets a type 2 diagnosis and you start to wonder about yourself. The odd thing is that you feel fine. You are not overweight. You eat reasonably well. So the number does not match the story you had about your own health.

Here is the honest version. Feeling well and being a healthy weight are both reassuring, and both incomplete. The process behind type 2 risk is quiet, and it starts years before anything shows up on a standard test. So this is not about effort. You can be doing the right things and still not know whether they are working, because the usual checklist, lose weight, move more, eat better, cannot tell you what is actually driving your risk, or whether it even applies to you.

This piece is about understanding your type 2 risk factors and what influences them. It is not about diagnosing or treating diabetes, which is a conversation for you and a clinician.

What rising type 2 diabetes risk actually is

The story starts in your fat tissue, not your pancreas.

Healthy fat tissue works a bit like a tide. It takes fat in after meals and releases it between them. The trouble begins when that tissue is chronically overfilled and can no longer hold what comes in. The tide stops working, the cells are full, and fat starts leaking out continuously. That spilled fat has to go somewhere, and where it goes is the problem. Instead of sitting safely under the skin, it builds up as visceral fat packed around your organs, and it starts depositing inside tissues that were never meant to store it: muscle, and above all the liver, which tends to take the first hit.

Once fat accumulates inside those cells, it jams insulin's signal. Muscle is the body's largest store for glucose, so when it stops responding to insulin, glucose loses its most generous home. To get the same amount of glucose put away, the body has to make more and more insulin. One way to picture it: the pancreas ends up having to shout to be heard, where a normal voice used to do.

For a long time, shouting works. Glucose stays normal precisely because insulin is quietly climbing behind the scenes. That stage, where insulin is already high and glucose is only just starting to drift up, is what prediabetes describes (a defined HbA1c band just below the diabetes threshold). None of this happens overnight. It builds over years, and in long-running cohort data insulin sensitivity can be seen falling well before any diagnosis. It is a slow slide, not a switch that flips.

This is also why a diagnosis arrives late. Diabetes is defined by glucose that has already risen past set thresholds, but by then the underlying change has been building quietly for years. Glucose climbs only when that balancing act finally gives way, either because the tissues stop responding or, later, because the pancreas itself tires. The number on the day is the last thing to move, not the first.

The established risk factors

Three levers do most of the work, and they line up cleanly against what you can and cannot change.

The first is how much fat your under-skin tissue can safely hold before it overflows. This is largely genetic and linked to ancestry. Some people have a large safe store and can gain a fair amount of fat while staying insulin sensitive, because it stays where it belongs. Others, people of South Asian ancestry in particular, have a smaller safe store, so the overflow into visceral and organ fat happens earlier and at a lower body weight.

The second is muscle, both how much you have and how much you use it. Muscle is the biggest glucose sink, so more of it means more capacity to soak up fuel from food. What matters is really the ratio of fat to muscle, not either one alone.

The third is activity. The more you move, the more glucose your muscle pulls in, partly through a route that does not need insulin at all during contraction. Movement can lower risk through that mechanism, as well as by shifting the first two levers.

Underneath all three sit the things you cannot change: your genetics, your ancestry, your inherited storage capacity, and your age, since muscle gets harder to build and hold as you get older. A useful way to hold it: you do not choose the terrain, but you very much influence the pace.

Two signals are worth calling out for women specifically, because they often show up in this decade. Polycystic ovary syndrome is, for many women, an insulin-resistant state, and a history of gestational diabetes marks a raised long-term risk. Both are better read as forward-looking signals than as closed chapters.

Why generic "lose weight, move more" advice falls short

It is silent. Insulin resistance usually has no clear symptom. Someone very tuned in might notice softer signals, an afternoon energy crash, a blood pressure creeping upward, disrupted or poor-quality sleep that can point to sleep apnoea, or changes in sexual function, since the small blood vessels involved are sensitive to these early shifts. But plenty of people feel nothing at all.

A healthy weight does not clear you. You can be lean, feel well, consider yourself healthy, and still measure poorly when insulin sensitivity is actually tested. The pattern of being thin on the outside but carrying fat inside, in the liver and around the organs, is real and easy to miss.

A questionnaire predicts; it does not measure. UK risk checkers such as Diabetes UK's Know Your Risk tool estimate your risk from the factors that shape it, like ancestry, age and activity. They are useful for what they are, but each input is a weak signal on its own. A questionnaire can tell you that you are the sort of person who tends to be at higher risk. It cannot tell you where you personally sit.

HbA1c on its own lags. It reflects your average glucose once glucose has already started to rise, so it misses the years when insulin is climbing and glucose still looks normal.

A single reading misleads. Risk is built by cumulative exposure over time, closer to the total area under the curve than to any one day's number. The trajectory is the thing that matters, and a single measurement can misclassify you badly.

Your data rarely connects. Your wearable, your GP notes and your blood tests tend to live in separate places, so nobody is reading the trend across them.

Working out which risk factors are actually yours

The aim is to get as close as possible to seeing insulin sensitivity, the thing you actually care about, rather than guessing at it.

The most convenient read is a fasting blood draw that measures glucose and insulin together, combined into a single index (HOMA-IR). It needs nothing more than one morning sample and tracks closely with the research gold standard. If you want more resolution, a glucose tolerance test with insulin measured alongside gets you closer still.

Body composition fills in the rest. Visceral fat and muscle mass can be measured together with a DEXA scan, which uses an ultra-low radiation dose, and high visceral fat is one of the strongest signals that your safe storage is starting to overflow. Movement is exactly the kind of data a wearable captures well.

The bigger point is trend over snapshot. Adding points over time resolves your trajectory, and the trajectory is what you act on. This is why two people can get completely different advice from the same risk score: their underlying data is different. For someone in an at-risk picture, the fast-moving markers, glucose, insulin and visceral fat, are worth re-checking roughly once a year, and more often if you are actively making changes and want to see whether they are working.

What you can do once you know your drivers

Mechanistically, the lever is the fat tissue. The aim is to ease the overload so it can go back to storing and releasing in its normal rhythm, instead of leaking fat into the liver and muscle. Shifting your energy balance, a little less in and a little more out, can do that, and the readouts that tell you it is working are visceral fat and insulin sensitivity, the same two numbers running through this whole piece.

Here is the part generic advice skips. When you have carried extra weight for a while, your body starts to defend it. As fat comes down, the hormone your fat cells use to signal how much fuel is in store falls too, and your brain reads that as the stores shrinking and pushes back, easing your resting metabolic rate down and quietly reducing how much you move. This is physiology, not a willpower failure, and it is a large part of why sustained weight loss is genuinely hard.

So the useful approach works with that pushback rather than against it. Muscle is the most helpful lever: resistance training raises the energy you burn and expands your glucose sink at the same time. It is slower to show than cardio, but the effect lasts far longer. Supporting your appetite with higher-fibre, higher-protein food helps too, so that eating a little less is tolerable rather than a constant fight.

Bring in a clinician when lifestyle changes are not shifting your visceral fat or insulin sensitivity, when a diagnosis is already on the table, or when you want to talk through whether medication has a role for you. Some newer, prescribed and monitored options act on that counter-regulation directly. They are not for everyone, and a clinical conversation is the right place to weigh them.

Where Calibre fits

Once the picture is this specific, generic advice is the thing holding you back, not a lack of effort. This is the gap Calibre is built for.

• Bring your scattered markers into one clear picture of your risk factors: glucose, insulin, visceral fat and movement, read together rather than one reading at a time.

• Identify which of your risk factors to act on first, so your effort goes where your own data says it will count.

• Track those markers over time so you can see the trend move, which is what actually tells you whether it is working.

• It is clinician-led, with a CQC-regulated clinical partner, applied to your own data.

To be clear about what this is and is not: it is about understanding the risk factors at work in your body and what is driving them, so you can act on the right things. It is not a promise to prevent disease.

FAQs

Can you actually prevent type 2 diabetes, or only lower your risk? The honest framing is that your fixed factors, your genetics, ancestry and age, set your starting point and how steep the path is, while the modifiable ones, visceral fat, muscle, activity and diet, determine how fast you travel along it. A great deal is genuinely influenceable. The goal is to lower your risk and change your trajectory, not to bank on a guarantee.

What actually causes type 2 diabetes to develop? Fat tissue overflows its safe storage, and the spilled fat ends up in the liver, in muscle and around the organs, where it jams insulin's signal. The body compensates by making ever more insulin, so glucose looks normal for years. A diagnosis only shows up once that compensation finally gives way and glucose rises.

Which type 2 diabetes risk factors can I change, and which can't I? Changeable: visceral fat, muscle mass, activity and diet. Fixed: your genetics, ancestry, inherited fat-storage capacity, and age. The fixed ones set the starting line; the changeable ones set the pace.

What's the difference between a diabetes risk score and a blood test? A questionnaire predicts your risk from factors linked to it. It is useful, but each factor is a weak signal, and it cannot measure your actual insulin sensitivity. A blood test, fasting glucose with fasting insulin, or a glucose tolerance test with insulin, gets much closer to where you personally sit.

Can I be at higher risk even if I'm a healthy weight? Yes. Insulin resistance is largely silent, and some people are lean, feel fine and still test poorly, particularly where their safe fat-storage capacity is smaller. A normal weight is reassuring, but it is not a clearance.

Does a family history of type 2 diabetes mean I'll get it? No. Family history and ancestry raise your starting risk and can steepen the slope, but they do not fix the outcome. How you handle the modifiable factors still shapes where you end up.

Which blood markers show whether my type 2 risk is rising? Fasting glucose with fasting insulin, combined into a single index, is the convenient core, and a glucose tolerance test with insulin adds resolution. HbA1c is useful but lags, because it only moves once glucose is already rising. Visceral fat is a strong structural signal alongside them.

How often should I retest my blood sugar markers? For someone in an at-risk picture, the fast-moving markers, glucose, insulin and visceral fat, are worth checking about once a year, and more often if you are actively making changes and want to see whether they are working. The trend matters more than any single reading.

References

1. Matthews DR, et al. "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man." Diabetologia. 1985;28(7):412-419. doi:10.1007/BF00280883

2. DeFronzo RA, Tobin JD, Andres R. "Glucose clamp technique: a method for quantifying insulin secretion and resistance." Am J Physiol. 1979;237(3):E214-E223. PMID 382871.

3. Tabák AG, et al. "Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study." Lancet. 2009;373(9682):2215-2221. doi:10.1016/S0140-6736(09)60619-X

4. Rosenbaum M, Leibel RL. "Adaptive thermogenesis in humans." Int J Obes (Lond). 2010;34(Suppl 1):S47-S55. doi:10.1038/ijo.2010.184

5. Wilding JPH, et al. "Once-weekly semaglutide in adults with overweight or obesity" (STEP 1). N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183

6. Jastreboff AM, et al. "Tirzepatide once weekly for the treatment of obesity" (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PMID 35658024.

7. Lean MEJ, et al. "Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial." Lancet. 2018;391(10120):541-551. PMID 29221645.

8. Petersen KF, et al. "Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men." PNAS. 2006;103(48):18273-18277.

9. Lotta LA, et al. "Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance." Nat Genet. 2017;49(1):17-26.

10. Sniderman AD, et al. "Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis." Int J Epidemiol. 2007;36(1):220-225.

11. Taylor R. "Twin cycle hypothesis: personal fat threshold and beta-cell function in type 2 diabetes." (PMC7673778)

12. World Health Organization / American Diabetes Association. Diagnostic criteria for diabetes and prediabetes (fasting plasma glucose, 2-hour OGTT and HbA1c thresholds). WHO 2006/2011; ADA Standards of Care in Diabetes.

13. Diabetes UK "Know Your Risk" tool, based on the QDiabetes algorithm (Hippisley-Cox J, et al. BMJ. 2017) and the Leicester Diabetes Risk Score (Gray LJ, et al. Diabet Med. 2010).